142
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema

ORCID Icon, , , , , , , , , , , , , , & show all
Pages 1495-1506 | Published online: 01 Jul 2022

References

  • Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–593. doi:10.1183/09031936.05.00021005
  • Jankowich MD, Rounds SIS. Combined pulmonary fibrosis and emphysema syndrome. Chest. 2012;141(1):222–231. doi:10.1378/chest.11-1062
  • Plantier L, Cazes A, Dinh-Xuan AT, Bancal C, Marchand-Adam S, Crestani B. Physiology of the lung in idiopathic pulmonary fibrosis. Eur Respir Rev. 2018;27(147):170062. doi:10.1183/16000617.0062-2017
  • Orens JB, Kazerooni EA, Martinez FJ, et al. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. Chest. 1995;108(1):109–115. doi:10.1378/chest.108.1.109
  • du Bois RM, Weycker D, Albera C, et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011;184(12):1382–1389. doi:10.1164/rccm.201105-0840OC
  • Amariei DE, Dodia N, Deepak J, et al. Combined pulmonary fibrosis and emphysema: pulmonary function testing and a pathophysiology perspective. Medicina. 2019;55(9):580. doi:10.3390/medicina55090580
  • Pastre J, Plantier L, Planes C, et al. Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases. BMC Pulm Med. 2015;15(1):100. doi:10.1186/s12890-015-0084-1
  • Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144(1):234–240. doi:10.1378/chest.12-2403
  • Kaminsky DA, Whitman T, Callas PW. DLCO versus DLCO/VA as predictors of pulmonary gas exchange. Respir Med. 2007;101(5):989–994. doi:10.1016/j.rmed.2006.09.003
  • Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J. 2011;38(1):176–183. doi:10.1183/09031936.00114010
  • Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026–1041. doi:10.1183/09031936.03.00089403
  • Horsley A, Siddiqui S. Putting lung function and physiology into perspective: cystic fibrosis in adults. Respirology. 2015;20(1):33–45. doi:10.1111/resp.12382
  • King GG, Bates J, Berger KI, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753. doi:10.1183/13993003.00753-2019
  • Yamamoto Y, Miki K, Tsujino K, et al. Oscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2020;6(4):00391–02020. doi:10.1183/23120541.00391-2020
  • Dellacà RL, Santus P, Aliverti A, et al. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J. 2004;23(2):232–240. doi:10.1183/09031936.04.00046804
  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: https://ginasthma.org/. Accessed May 25, 2021.
  • Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68. doi:10.1164/rccm.201807-1255ST
  • Shirai T, Kurosawa H. Clinical application of the forced oscillation technique. Intern Med. 2016;55(6):559–566. doi:10.2169/internalmedicine.55.5876
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Kubota M, Kobayashi H, Quanjer PH, et al. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52(4):242–250. doi:10.1016/j.resinv.2014.03.003
  • Buist AS, Ross BB. Predicted values for closing volumes using a modified single breath nitrogen test | American review of respiratory disease. Am Rev Respir Dis. 1973;107(5):744–752. doi:10.1164/arrd.1973.107.5.744
  • Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016. doi:10.1183/13993003.00016-2016
  • Burrows B, Kaslik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis. 1961;84(6):789–806. doi:10.1164/arrd.1961.84.6.789
  • Mori Y, Nishikiori H, Chiba H, Yamada G, Kuronuma K, Takahashi H. Respiratory reactance in forced oscillation technique reflects disease stage and predicts lung physiology deterioration in idiopathic pulmonary fibrosis. Respir Physiol Neurobiol. 2020;275:103386. doi:10.1016/j.resp.2020.103386
  • Zielonka TM, Demkow U, Radzikowska E, et al. Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function. Eur J Med Res. 2010;15(Suppl 2):229–234. doi:10.1186/2047-783x-15-s2-229
  • Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113–1130. doi:10.1183/13993003.02316-2014
  • Gagnon P, Guenette JA, Langer D, et al. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:187–201. doi:10.2147/COPD.S38934
  • Akita T, Shirai T, Mori K, et al. Association of the forced oscillation technique with negative expiratory pressure in COPD. Respir Physiol Neurobiol. 2016;220:62–68. doi:10.1016/j.resp.2015.09.002
  • Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol. 2011;45(1):1–15. doi:10.1165/rcmb.2010-0365TR
  • Agustí AGN, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;143(2):219–225. doi:10.1164/ajrccm/143.2.219
  • Cortes-Telles A, Forkert L, O’Donnell DE, Morán-Mendoza O. Idiopathic pulmonary fibrosis: new insights to functional characteristics at diagnosis. Can Respir J. 2014;21(3):e55–e60. doi:10.1155/2014/825606
  • Sakao S, Voelkel NF, Tatsumi K. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations. Eur Respir Rev. 2014;23(133):350–355. doi:10.1183/09059180.00007913
  • Matsuoka S, Washko GR, Yamashiro T, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med. 2010;181(3):218–225. doi:10.1164/rccm.200908-1189OC
  • Jacob J, Bartholmai BJ, Rajagopalan S, et al. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis. Eur Respir J. 2017;50(1):1700379. doi:10.1183/13993003.00379-2017
  • Balasubramanian A, MacIntyre NR, Henderson RJ, et al. Diffusing capacity of carbon monoxide in assessment of COPD. Chest. 2019;156(6):1111–1119. doi:10.1016/j.chest.2019.06.035
  • Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med. 1997;155(4):1367–1375. doi:10.1164/ajrccm.155.4.9105081
  • Stam H, Kreuzer FJ, Versprille A. Effect of lung volume and positional changes on pulmonary diffusing capacity and its components. J Appl Physiol. 1991;71(4):1477–1488. doi:10.1152/jappl.1991.71.4.1477
  • Dellacà RL, Duffy N, Pompilio PP, et al. Expiratory flow limitation detected by forced oscillation and negative expiratory pressure. Eur Respir J. 2007;29(2):363–374. doi:10.1183/09031936.00038006
  • Suh ES, Pompilio P, Mandal S, et al. Autotitrating external positive end-expiratory airway pressure to abolish expiratory flow limitation during tidal breathing in patients with severe COPD: a physiological study. Eur Respir J. 2020;56(3):1902234. doi:10.1183/13993003.02234-2019